Katalog der Deutschen Nationalbibliothek

Expertensuche ?

Servicezeiten in Frankfurt am Main ab 1. Dezember 2025: Montag bis Freitag 9–18 Uhr und Samstag 10–16 Uhr
Service hours in Frankfurt am Main from 1 December 2025: Monday to Friday 9:00-18:00 and Saturday 10:00-16:00

Dienstag 9. Dezember 2025: Die Lesesäle der Deutschen Nationalbibliothek in Leipzig öffnen wegen einer Personalversammlung erst ab 13 Uhr. // Tuesday 9 December 2025: The reading rooms of the German National Library in Leipzig will open at 13:00 due to a staff assembly.

Ergebnis der Suche nach: "Originator"
im Bestand: Gesamter Bestand

11 - 20 von 129

	11	Reverse switching from the biosimilar SB2 to the originator infliximab in previously switched patients with inflammatory bowel diseases: results of a prospective long-term cohort study Fischer, Sarah. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2024
	12	Inpatient Infliximab Biosimilar Cost-Savings: Cost Analysis of Inpatient Treatment with Originator Infliximab (Remicade ™) versus Biosimilar Infliximab (Renflexis ™) for Acute Severe Ulcerative Colitis Enthalten in Digestive diseases Bd. 42, 2024, Nr. 5: 496-502. 6 S.
	13	The annual update GLODAPv2.2023: the global interior ocean biogeochemical data product Enthalten in Earth system science data Bd. 16, 2024, Nr. 4: 2047-2072. 26 S.
	14	Conjugation of Polycationic Peptides Extends the Efficacy Spectrum of β‐Lactam Antibiotics Enthalten in Advanced science 05.11.2024. 12 S.
	15	Real-World Comparative Analysis of Trastuzumab Originator and Biosimilars: Safety, Efficacy, and Cost Effectiveness Enthalten in BioDrugs 16.10.2024: 1-12
	16	Effectiveness and Safety Data in Rheumatoid Arthritis Patients after Switching from Originator Rituximab to Biosimilar Rituximab (CT-P10) Enthalten in Aktuelle Rheumatologie 01.10.2024
	17	Safety profile of trastuzumab originator vs biosimilars: a systematic review and meta-analysis of randomized clinical trials Enthalten in Clinical and translational oncology 18.9.2024: 1-13
	18	Clinical Utilization of Generic Drugs and Biosimilars for Ulcerative Colitis Treatment: Insights from a Nationwide Database Study in Japan Enthalten in Inflammatory intestinal diseases Bd. 9, 2024, Nr. 1: 29-39. 11 S.
	19	Switching from adalimumab originator to biosimilar in patients with hidradenitis suppurativa results in losses of response — data from the German HS registry HSBest Kirsten, Natalia. - Würzburg : Universität Würzburg, 2023
	20	In Defense of Disinformation Enthalten in Journal of homeland security and emergency management Bd. 21, 2023, Nr. 3: 441-466. 26 S.